Can in vivo assessment of tissue hemodynamics with dynamic contrast-enhanced CT be used in the diagnosis of tumors and monitoring of cancer therapy outcomes?

Radiology

Volumn 232, Issue 3, 2004, Pages 631-632

  Sobol, Wlad T ^a   Cure, Joel K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME; TUMOR;

CONTRAST MEDIA; HEMODYNAMIC PROCESSES; HUMANS; NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 4143056823     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2323040625     Document Type: Short Survey

References (4)

1. Lee TY. Functional CT: physiological models. Trends Biotechnol 2002; 20(suppl 8):S3-S10.
2. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10:223-232.
3. Cheong LH, Lim CC, Koh TS. Dynamic contrast-enhanced CT imaging of intracranial meningioma: a comparison of distributed and compartmental tracer kinetics models-initial results. Radiology 2004; 232:921-930.
4. Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 1999; 10:903-907.